Research studies are the only way new drugs can be made ready for doctors to prescribe to patients. If you have cervical dystonia and are between the ages of 18 and 80, consider the ASPEN study of a new investigational drug called DAXI for injection, a long-acting form of botulinum toxin. In other studies, DAXI […]
DMRF Tackles Urgent Need for Movement Disorder Specialists
The Dystonia Medical Research Foundation (DMRF) announced Abhimanyu Mahajan, MD, MHS, University of Cincinnati, as the latest recipient of the DMRF Clinical Fellowship Award to support training in the diagnosis and treatment of movement disorders with special expertise in dystonia. Dr. Mahajan’s mentor is Alberto J. Espay, MD, MSc, Professor of Neurology, Director, James J. […]
Cross-Disciplinary Projects Explore Dystonia Brain Networks to Improve Diagnosis & Treatment
The Dystonia Medical Research Foundation (DMRF) and Cure Dystonia Now (CDN) announced the latest grant awards to advance research toward improved dystonia treatment options and ultimately a cure. Dystonia is the third most common movement disorder, affecting no fewer than 250,000 Americans and potentially millions worldwide. This marks the latest in an ongoing collaboration between […]
DMRF Welcomes New Scientific Director
The DMRF is pleased to announce the appointment of Joel S. Perlmutter, MD as Scientific Director. He is pictured (R) with Scientific Director Emeritus, Mahlon Delong, MD. Dr. Perlmutter is the Elliot H. Stein Family Professor of Neurology and Professor of Radiology, Neuroscience, Physical Therapy and Occupational Therapy; and Head of the Movement Disorders Section […]
On Target: Drug Discovery Efforts Pursue New & Improved Treatment
This article originally appeared in the Dystonia Dialogue. Drug discovery and development efforts are an important part of the Dystonia Medical Research Foundation’s (DMRF) multi-faceted science strategy. “The dystonia community cannot wait for pharmaceutical and biotech companies to necessarily get interested in dystonia on their own,” explains Jan Teller, MA, PhD, DMRF’s Chief Scientific Advisor. […]
Groundbreaking Investigations Seek Cure for Disabling Childhood Dystonia
The Dystonia Medical Research Foundation (DMRF) announced its latest post-doctoral fellowship awards to advance research toward improved dystonia treatments and a cure. For more than 40 years, the DMRF has funded dystonia science and created opportunities for young investigators to establish careers in this growing field. Dystonia is the third most common movement disorder, affecting […]
RGS9-2 Protein Corrects Dopamine Imbalance in DYT1 Dystonia Models
A new study led by Antonio Pisani, MD, PhD of University of Rome Tor Vergata, offers new insights into the role of dopamine in DYT1 dystonia. It may also explain why DYT1 dystonia patients vary in their response to dopamine-boosting medications such as levodopa. The work of Dr. Pisani and his group may inspire new drug […]
Thank You for Supporting DMRF
With the support of our generous members, donors, and volunteers, we were able to accomplish a tremendous amount in 2018. Please click below to watch a special video ‘thank you’ recorded by DMRF President Art Kessler which details the many accomplishments that were made possible this year. If you have not yet made your gift, […]
Self-Care for the Holidays
Feeling a little stressed? A lot stressed? In case you missed the live broadcast, “Self Care for the Holidays” with Margie Frazier, PhD, LISW-S, is available for viewing. Give yourself a gift this season and treat yourself to this wonderful program. The Dystonia Medical Research Foundation is a 501(c)(3) non-profit organization dedicated to advancing research […]